| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0003-2327 | YERVOY | ipilimumab | E.R. Squibb & Sons, L.L.C. | INJECTION | 2011-03-25 | |
| 0003-2328 | YERVOY | ipilimumab | E.R. Squibb & Sons, L.L.C. | INJECTION | 2011-03-25 | |
| 0078-0846 | KYMRIAH | tisagenlecleucel | Novartis Pharmaceuticals Corporation | INJECTION, SUSPENSION | 2017-08-30 | |
| 0078-0958 | KYMRIAH | tisagenlecleucel | Novartis Pharmaceuticals Corporation | INJECTION, SUSPENSION | 2018-05-01 | |
| 0310-4505 | IMJUDO | tremelimumab | AstraZeneca Pharmaceuticals LP | INJECTION, SOLUTION | 2022-10-21 | |
| 0310-4535 | IMJUDO | tremelimumab | AstraZeneca Pharmaceuticals LP | INJECTION, SOLUTION | 2022-10-21 | |
| 71287-119 | YESCARTA | axicabtagene ciloleucel | Kite Pharma, Inc. | SUSPENSION | 2017-10-18 |
Loading full table content...